Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (43)
Renata B. Albuquerque, Maria Amélia S. M. Borba, Matheus S. S. Fernandes, Tayrine O. Filgueira, Danyelly Bruneska G. Martins, José Luiz L. Filho, Angela Castoldi & Fabrício Oliveira Souto. (2023) Interleukin-33 Expression on Treatment Outcomes and Prognosis in Brazilian Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy. International Journal of Molecular Sciences 24:22, pages 16326.
Crossref
Crossref
Binhao Chen & Weifeng Jin. (2023) A comprehensive review of stroke-related signaling pathways and treatment in western medicine and traditional Chinese medicine. Frontiers in Neuroscience 17.
Crossref
Crossref
Laura Francesca Pisani, Isabella Teani, Maurizio Vecchi & Luca Pastorelli. (2023) Interleukin-33: Friend or Foe in Gastrointestinal Tract Cancers?. Cells 12:11, pages 1481.
Crossref
Crossref
Milica M. Borovcanin, Katarina Vesić, Dragana Arsenijević, Maja Milojević-Rakić, Nataša R. Mijailović & Ivan P. Jovanovic. (2023) Targeting Underlying Inflammation in Carcinoma Is Essential for the Resolution of Depressiveness. Cells 12:5, pages 710.
Crossref
Crossref
Rajdeep Chakraborty, Charbel Darido, Fei Liu, Maciej Maselko & Shoba Ranganathan. (2023) Head and Neck Cancer Immunotherapy: Molecular Biological Aspects of Preclinical and Clinical Research. Cancers 15:3, pages 852.
Crossref
Crossref
Ana Divjak, Ivan Jovanovic, Aleksandar Matic, Aleksandra Tomic Lucic, Nevena Gajovic, Milena Jurisevic, Aleksandra Jurisic Skevin & Mirjana Veselinovic. (2022) The influence of vitamin D supplementation on the expression of mediators of inflammation in knee osteoarthritis. Immunologic Research.
Crossref
Crossref
Runzi Sun, David Shihong Gao, Jason Shoush & Binfeng Lu. (2022) The IL-1 family in tumorigenesis and antitumor immunity. Seminars in Cancer Biology 86, pages 280-295.
Crossref
Crossref
Xue-Mei Yi, Huan Lian & Shu Li. (2022) Signaling and functions of interleukin-33 in immune regulation and diseases. Cell Insight 1:4, pages 100042.
Crossref
Crossref
Bart Boersma, Wim Jiskoot, Peter Lowe & Carole Bourquin. (2021) The interleukin-1 cytokine family members: Role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapy. Cytokine & Growth Factor Reviews 62, pages 1-14.
Crossref
Crossref
Mi-Ran Choi, Jeffrey A. Sosman & Bin Zhang. (2021) The Janus Face of IL-33 Signaling in Tumor Development and Immune Escape. Cancers 13:13, pages 3281.
Crossref
Crossref
Wei Yuan, Xue Mei, Yu-yi Zhang, Zheng-guo Zhang, Ying Zou, Hui Zhu, Yu Liu, Jie-fei Wang, Zhi-ping Qian & Hong-zhou Lu. (2020) High Expression of Interleukin-33/ST2 Predicts the Progression and Poor Prognosis in Chronic Hepatitis B Patients with Hepatic Flare. The American Journal of the Medical Sciences 360:6, pages 656-661.
Crossref
Crossref
Astrid De Boeck, Bo Young Ahn, Charlotte D’Mello, Xueqing Lun, Shyam V. Menon, Mana M. Alshehri, Frank Szulzewsky, Yaoqing Shen, Lubaba Khan, Ngoc Ha Dang, Elliott Reichardt, Kimberly-Ann Goring, Jennifer King, Cameron J. Grisdale, Natalie Grinshtein, Dolores Hambardzumyan, Karlyne M. Reilly, Michael D. Blough, J. Gregory Cairncross, V. Wee Yong, Marco A. Marra, Steven J. M. Jones, David R. Kaplan, Kathy D. McCoy, Eric C. Holland, Pinaki Bose, Jennifer A. Chan, Stephen M. Robbins & Donna L. Senger. (2020) Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression. Nature Communications 11:1.
Crossref
Crossref
Borna Relja & Walter Gottlieb Land. (2019) Damage-associated molecular patterns in trauma. European Journal of Trauma and Emergency Surgery 46:4, pages 751-775.
Crossref
Crossref
Helene Hersvik Aarstad, Gigja Guðbrandsdottir, Karin M. Hjelle, Leif Bostad, Øystein Bruserud, Tor Henrik Anderson Tvedt & Christian Beisland. (2020) The Biological Context of C-Reactive Protein as a Prognostic Marker in Renal Cell Carcinoma: Studies on the Acute Phase Cytokine Profile. Cancers 12:7, pages 1961.
Crossref
Crossref
Cinzia Fionda, Helena Stabile, Cristina Cerboni, Alessandra Soriani, Angela Gismondi, Marco Cippitelli & Angela Santoni. (2020) Hitting More Birds with a Stone: Impact of TGF-β on ILC Activity in Cancer. Journal of Clinical Medicine 9:1, pages 143.
Crossref
Crossref
Marco Casciaro, Roberta Cardia, Eleonora Di Salvo, Giovanni Tuccari, Antonio Ieni & Sebastiano Gangemi. (2019) Interleukin-33 Involvement in Nonsmall Cell Lung Carcinomas: An Update. Biomolecules 9:5, pages 203.
Crossref
Crossref
Guanglin Cui, Jingli Ren, Gang Xu, Zhenfeng Li, Wei Zheng & Aping Yuan. (2018) Cellular and clinicopathological features of the IL-33/ST2 axis in human esophageal squamous cell carcinomas. Cancer Cell International 18:1.
Crossref
Crossref
Zivan M. Babic, Filip Z. Zunic, Jelena M. Pantic, Gordana D. Radosavljevic, Ivan P. Jovanovic, Nebojsa N. Arsenijevic & Miodrag L. Lukic. (2018) IL-33 receptor (ST2) deficiency downregulates myeloid precursors, inflammatory NK and dendritic cells in early phase of sepsis. Journal of Biomedical Science 25:1.
Crossref
Crossref
Kristen Larsen, Maydelis Minaya, Vivek Vaish & Maria Peña. (2018) The Role of IL-33/ST2 Pathway in Tumorigenesis. International Journal of Molecular Sciences 19:9, pages 2676.
Crossref
Crossref
Razieh Zare, Mahyar Malekzadeh, Mohamad Hashemi, Bijan Khademi & Azadeh Andishe-Tadbir. (2018) Investigation of IL-33 serum levels in patients with benign and malignant salivary gland tumors. Cancer Biomarkers 23:1, pages 61-65.
Crossref
Crossref
Jun‐Li Wang, Jia Liu, Ke‐Gong Xie, Chang‐Gong Lan, Lu Lu & Yu‐Jin Tang. (2018)
Association between functional polymorphisms in
IL‐33
/
ST2
pathway and risk of osteosarcoma
. Journal of Cellular and Molecular Medicine 22:8, pages 3808-3815.
Crossref
Crossref
Yanru Chen & Jihong Qian. (2018) Increased serum levels of IL‐33 and soluble ST2 in neonates with human cytomegalovirus infection. Journal of Medical Virology 90:8, pages 1383-1388.
Crossref
Crossref
Milica M. Borovcanin, Slavica M. Janicijevic, Ivan P. Jovanovic, Nevena Gajovic, Nebojsa N. Arsenijevic & Miodrag L. Lukic. (2018) IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis. Frontiers in Psychiatry 9.
Crossref
Crossref
Sachiko Hiraide, Yoshiki Yanagawa & Kenji Iizuka. (2018) Tranilast inhibits interleukin-33 production by macrophages. European Journal of Pharmacology 818, pages 235-240.
Crossref
Crossref
Grzegorz WicherUlrika WallenquistYing LeiMattias EnokssonXiaofei LiBarbara FuchsSami Abu HamdehNiklas MarklundLars HilleredGunnar NilssonKarin Forsberg-Nilsson. (2017) Interleukin-33 Promotes Recruitment of Microglia/Macrophages in Response to Traumatic Brain Injury. Journal of Neurotrauma 34:22, pages 3173-3182.
Crossref
Crossref
Joel Ohana, Uziel Sandler, Gideon Kass, Salomon Stemmer & Yoram Devary. (2017) dTCApFs, a derivative of a novel human hormone peptide, induces apoptosis in cancer cells through a mechanism involving loss of Golgi function. Molecular and Clinical Oncology.
Crossref
Crossref
Zewei Wang, Le Xu, Yuan Chang, Lin Zhou, Hangcheng Fu, Weijuan Zhang, Yuanfeng Yang & Jiejie Xu. (2016) IL-33 is associated with unfavorable postoperative survival of patients with clear-cell renal cell carcinoma. Tumor Biology 37:8, pages 11127-11134.
Crossref
Crossref
DOROTHEE GRAMATZKI, KARL FREI, GIERI CATHOMAS, HOLGER MOCH, MICHAEL WELLER & KIRSTEN DIANA MERTZ. (2016) Interleukin-33 in human gliomas: Expression and prognostic significance. Oncology Letters 12:1, pages 445-452.
Crossref
Crossref
Vikram Mehraj, Rosalie Ponte & Jean-Pierre Routy. (2016) The Dynamic Role of the IL-33/ST2 Axis in Chronic Viral-infections: Alarming and Adjuvanting the Immune Response. EBioMedicine 9, pages 37-44.
Crossref
Crossref
Milos Z. Milosavljevic, Ivan P. Jovanovic, Nada N. Pejnovic, Slobodanka L. J. Mitrovic, Nebojsa N. Arsenijevic, Bojana J. Simovic Markovic & Miodrag L. Lukic. (2016) Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma. Oncotarget 7:14, pages 18106-18115.
Crossref
Crossref
Duvini De Silva, Kamini Kunasegaran, Sujoy Ghosh & Alexandra M Pietersen. (2015) Transcriptome analysis of the hormone-sensing cells in mammary epithelial reveals dynamic changes in early pregnancy. BMC Developmental Biology 15:1.
Crossref
Crossref
Myung Shin Kim, Eunsom Kim, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Wook Lee, Tae-Hyeong Lee, Hyeon Ju Lee, Hun Soo Chang, Jong Sook Park, An Soo Jang, Eun Suk Koh, Hun Gyu Hwang, Guneil Lim, Soohyun Kim & Choon-Sik Park. (2015) Circulating IL-33 level is associated with the progression of lung cancer. Lung Cancer 90:2, pages 346-351.
Crossref
Crossref
T. Aparicio. (2015) Le système immunitaire dans la carcinogenèse colorectale : ami ou ennemi ?Immune system during colorectal carcinogenesis: friend or foe?. Côlon & Rectum 9:4, pages 217-223.
Crossref
Crossref
Yanhong Shi, Zhenfeng Li, Wei Zheng, Xia Liu, Chenyi Sun, Jann-Birger Laugsand, Zhanju Liu & Guanglin Cui. (2015) Changes of immunocytic phenotypes and functions from human colorectal adenomatous stage to cancerous stage: Update. Immunobiology 220:10, pages 1186-1196.
Crossref
Crossref
Erica Maria Pimenta, Saurav De, Ryan Weiss, Di Feng, Kelly Hall, Sarah Kilic, Gyan Bhanot, Shridar Ganesan, Sophia Ran & Betsy J Barnes. (2014)
IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5
+
B‐ and T‐cell trafficking to tumor‐conditioned media
. Immunology & Cell Biology 93:5, pages 486-499.
Crossref
Crossref
Xi-Xiang Yu, Zhe Hu, Xian Shen, Li-Yang Dong, Wei-Zhong Zhou & Wen-Hao Hu. (2015) IL-33 Promotes Gastric Cancer Cell Invasion and Migration Via ST2–ERK1/2 Pathway. Digestive Diseases and Sciences 60:5, pages 1265-1272.
Crossref
Crossref
Guanglin Cui, Haili Qi, Mona D. Gundersen, Hang Yang, Ingrid Christiansen, Sveinung W. Sørbye, Rasmus Goll & Jon Florholmen. (2014) Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer. Cancer Immunology, Immunotherapy 64:2, pages 181-190.
Crossref
Crossref
Arseniy E. Yuzhalin & Anton G. Kutikhin. 2015. Interleukins in Cancer Biology. Interleukins in Cancer Biology
17
61
.
Wen-Ting Hu, Ming-Qing Li, Wei Liu, Li-Ping Jin, Da-Jin Li & Xiao-Yong Zhu. (2014) IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-κB and ERK1/2 signaling. MHR: Basic science of reproductive medicine 20:4, pages 358-372.
Crossref
Crossref
Yongqiang Sun, Ji-Yuan Zhang, Sa Lv, Huan Wang, Man Gong, Ning Du, Honghong Liu, Ning Zhang, Jing Jing, Chao Zhou, Fan Zhang & Zongren Wang. (2014) Interleukin-33 Promotes Disease Progression in Patients with Primary Biliary Cirrhosis. The Tohoku Journal of Experimental Medicine 234:4, pages 255-261.
Crossref
Crossref
Dominik Bergis, Valentin Kassis, Annika Ranglack, Verena Koeberle, Albrecht Piiper, Bernd Kronenberger, Stefan Zeuzem, Oliver Waidmann & Heinfried H Radeke. (2013) High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma. Translational Oncology 6:3, pages 311-318.
Crossref
Crossref
P. Han, J. Zhao, S.-B. Liu, C.-J. Yang, Y.-Q. Wang, G.-C. Wu, D.-M. Xu & W.-L. Mi. (2013) Interleukin-33 mediates formalin-induced inflammatory pain in mice. Neuroscience 241, pages 59-66.
Crossref
Crossref
Marija Milovanovic, Vladislav Volarevic, Gordana Radosavljevic, Ivan Jovanovic, Nada Pejnovic, Nebojsa Arsenijevic & Miodrag L. Lukic. (2012) IL-33/ST2 axis in inflammation and immunopathology. Immunologic Research 52:1-2, pages 89-99.
Crossref
Crossref